Barbieri M, Senese F, Mellott CE, Boccalini S, Carrico J, Bechini A, Talbird SE, Chen Y-H, Bencina G. Public health impact and return on investment of the pediatric national immunization program in Italy. Presented at the Italian Society of Hygiene, Preventive Medicine, and Public Health Conference; October 12, 2023. Cernobbio, Italy.
Seeger JD, Jonsson Funk M, Bradley Layton J, Lloyd P. Considerations of misclassification and confounding on COVID-19 vaccines effectiveness studies - a Vaccine SIG endorsed symposium. Presented at the 2022 ICPE Conference; August 26, 2022. Copenhagen, Denmark.
Talbird S, Carrico J. Cost-benefit analysis of vaccination against four preventable diseases in older adults: impact of an aging population. Presented at the 2021 National Adult and Influenza Immunization Summit Virutal Meeting; August 26, 2021.
La E, Poston S, Curran D, Lorenc S, Salem AE, Carrico J, Hicks KA, Anderson S, Carpenter CF. Cost-effectiveness analysis of recombinant zoster vaccine for vaccinating immunocompromised adults against Herpes Zoster in the United States. Presented at the ACIP Herpes Zoster Working Group; April 2021. Atlanta, GA.
Hunter S, Garbinsky D, La EM, Poston S, Hogea C. Impact of state of residence on adult vaccination uptake: a multilevel modeling approach. Presented at the IDWeek 2020 Virtual Conference; October 21, 2020.
La EM, Garbinsky D, Hunter S, Poston S, Novy P, Ghaswalla P. Individual and state-level factors associated with receipt of multiple recommended adolescent vaccines in the United States. Presented at the IDWeek 2020 Virtual Conference; October 2020.
Herring W, Rosen B. Economic model for ResVax for maternal vaccination against infant respiratory syncytial virus disease in the United States. Presented at the 2019 Respiratory Syncytial Virus Consortium in Europe; June 2019. Utrecht, The Netherlands.
Kawai AT, Anderson S, Andrade SE, Zichittella L, Stockdale C. Developing capabilities to monitor the safety of vaccine use during pregnancy in Sentinel's Prism Program. Presented at the 4th International Neonatal & Maternal Immunization Symposium; September 2017. Brussels, Belgium.
Wasserman M, Rejas J, Mendez C, Wilson M, McDade C, Moffatt M, Farkouh R. Estimating clinical and economic impact of switching from the 13-valent (PCV13) to the 10-valent (PCV10) Pneumococcal Conjugate Vaccine in Spain. Presented at the 35th Annual Meeting of the European Society for Paediatric Infectious Diseases; May 24, 2017. Madrid, Spain.
Curran D, Van Oorschot D, Buck PO, Patterson BJ, Lee BY, Yawn BP, Hicks KA, Carrico J. Cost-effectiveness analysis of Shingrix for vaccinating US adults against herpes zoster. Presented at the ACIP Herpes Zoster Working Group; May 2017. Atlanta, GA.
Herring W, Rosen B. Early economic model for respiratory syncytial virus vaccination in older adults. Presented at the 2017 Respiratory Syncytial Virus Consortium in Europe; May 2017. Antwerp, Belgium.
Kawai AT. Assessment of febrile seizures after trivalent influenza vaccines during the 2010-2011 influenza season in PRISM. Presented at the Brookings Institution Roundtable on Active Medical Product Surveillance; July 21, 2014.
Davis KL, Kurosky SK. Recent trends in costs, length of stay, and mortality associated with infant pertussis hospitalization in the United States. Presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Kawai AT. Febrile seizures after TIV: PRISM System, 2010-2011 influenza season. Presented at the 2014 Advisory Committee on Immunization Practices (ACIP); June 2014. Atlanta, GA.
Brown DS, Johnson FR, Poulos C, Messonier MM. Mother-daughter preferences & willingness to pay for HPV vaccination. Presented at the 2nd Vaccine Global Congress; December 2008.
Poulos C, Malik R, Guh S, Utomo N, Nyamete A. Household demand for typhoid fever vaccines in North Jakarta, Indonesia. Presented at the 1st Vaccine Congress; December 2007.
Hicks KA, Honeycutt AA. Comparing children's immunization interventions: AFIX, RR, and WIC. Presented at the National Immunization Program Tuesday Seminar; January 2006.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Economics of hepatitis A immunization. Presented at the U.S. Advisory Committee on Immunization Practices; June 2005. Atlanta, GA.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Update: economics of hepatitis A virus immunization. Presented at the ACIP Hepatitis Working Group; June 2005.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Results of RTI's cost-effectiveness evaluation of childhood hepatitis A vaccination strategies. Presented at the U.S. Advisory Committee on Immunization Practices (ACIP); June 2005. Atlanta, GA.